Solvay, Drugmaker | featured news

Solvay sells drugs unit to Abbott for $6.6 billion

Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.61 billion) in cash and reinvest in chemicals and plastics.

 

Subscribe to this RSS topic: Syndicate content